Found: 26
Select item for more details and to access through your institution.
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 421, doi. 10.1002/ajh.26463
- By:
- Publication type:
- Article
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. 1236, doi. 10.1002/ajh.25628
- By:
- Publication type:
- Article
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0171041
- By:
- Publication type:
- Article
Primary Results of the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase (CP) Chronic Myeloid Leukemia (CML).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S290, doi. 10.1016/j.clml.2019.07.235
- By:
- Publication type:
- Article
Intensive Treatment and Stem Cell Transplantation in Chronic Myelogenous Leukemia: Long-Term Follow-Up.
- Published in:
- Acta Haematologica, 2005, v. 113, n. 3, p. 155, doi. 10.1159/000084445
- By:
- Publication type:
- Article
Long‐term tolerability and efficacy after initial PegIFN‐α addition to dasatinib in CML‐CP: Five‐year follow‐up of the NordCML007 study.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 6, p. 617, doi. 10.1111/ejh.13699
- By:
- Publication type:
- Article
Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 1, p. 57, doi. 10.1111/ejh.12785
- By:
- Publication type:
- Article
Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 4, p. 387, doi. 10.1111/ejh.12743
- By:
- Publication type:
- Article
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study ( Nord CML006).
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 3, p. 243, doi. 10.1111/ejh.12423
- By:
- Publication type:
- Article
Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinib Olsson-Strömberg et al. Monitoring dasatinib treated patients.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 5, p. 399, doi. 10.1111/j.1600-0609.2010.01506.x
- By:
- Publication type:
- Article
Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening.
- Published in:
- Cancer Informatics, 2022, v. 21, p. 1, doi. 10.1177/11769351221110872
- By:
- Publication type:
- Article
Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening.
- Published in:
- Cancer Informatics, 2022, v. 21, p. 1, doi. 10.1177/11769351221110872
- By:
- Publication type:
- Article
Long-term survival of fragment bonding in the treatment of fractured crowns: A multicenter clinical study.
- Published in:
- Quintessence International, 1995, v. 26, n. 10, p. 669
- By:
- Publication type:
- Article
Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registry.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 5, p. 915, doi. 10.1111/bjh.17392
- By:
- Publication type:
- Article
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 5, p. 683, doi. 10.1111/bjh.13346
- By:
- Publication type:
- Article
Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0055818
- By:
- Publication type:
- Article
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1395, doi. 10.1007/s00277-023-05199-1
- By:
- Publication type:
- Article
Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1046-y
- By:
- Publication type:
- Article
Endodontic treatment of experimentally induced apical periodontitis in dogs.
- Published in:
- Dental Traumatology, 1987, v. 3, n. 5, p. 240, doi. 10.1111/j.1600-9657.1987.tb00630.x
- By:
- Publication type:
- Article
Both CD4.
- Published in:
- Immunology, 2011, v. 133, n. 3, p. 296, doi. 10.1111/j.1365-2567.2011.03439.x
- By:
- Publication type:
- Article
T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies.
- Published in:
- Immunology, 2010, v. 131, n. 3, p. 371, doi. 10.1111/j.1365-2567.2010.03308.x
- By:
- Publication type:
- Article
Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
- Published in:
- Lipids in Health & Disease, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12944-023-01863-7
- By:
- Publication type:
- Article
Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 8, p. 1543, doi. 10.1007/s00432-017-2378-6
- By:
- Publication type:
- Article
Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 5, p. 1041, doi. 10.1007/s00432-015-2101-4
- By:
- Publication type:
- Article
Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0144787
- By:
- Publication type:
- Article